Travere Therapeutics Inc (NASDAQ:TVTX)
| 24.64 Delayed Data As of Sep 30 |  0.00 / 0.00%Today’s Change | 20.80 Today|||52-Week Range 31.65 | -20.62% Year-to-Date |
Latest TVTX News | Press Releases
No recent news for Travere Therapeutics Inc.
Today’s Trading
| Previous close | 24.64 |
| Today’s open | 25.18 |
| Day’s range | 24.64 - 25.84 |
| Volume | 20,801 |
| Average volume (3 months) | 708,686 |
| Market cap | $1.6B |
Data as of 4:01pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | +15.55% |
| Earnings growth (this year) | -33.28% |
| Earnings growth (next 5 years) | +137.00% |
| Revenue growth (last year) | +14.71% |
| P/E ratio | NM |
| Price/Sales | 8.16 |
| Price/Book | 5.12 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TLRYTilray Brands Inc | -0.11 | -3.85% |
| ALLOAllogene Therapeutic... | +0.49 | +4.75% |
| XNCRXencor Inc | +0.46 | +1.80% |
| IOVAIovance Biotherapeut... | +0.06 | +0.63% |
Data as of 4:02pm ET, 09/30/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$0.96 |
| Annual revenue (last year) | $227.5M |
| Annual profit (last year) | -$180.1M |
| Net profit margin | -79.16% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
